Cargando…

Metal-organic frameworks for advanced drug delivery

Metal-organic frameworks (MOFs), comprised of organic ligands and metal ions/metal clusters via coordinative bonds are highly porous, crystalline materials. Their tunable porosity, chemical composition, size and shape, and easy surface functionalization make this large family more and more popular f...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Siyu, Wu, Li, Li, Xue, Sun, Hongyu, Xiong, Ting, Liu, Jie, Huang, Chengxi, Xu, Huipeng, Sun, Huimin, Chen, Weidong, Gref, Ruxandra, Zhang, Jiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424373/
https://www.ncbi.nlm.nih.gov/pubmed/34522591
http://dx.doi.org/10.1016/j.apsb.2021.03.019
_version_ 1783749661755965440
author He, Siyu
Wu, Li
Li, Xue
Sun, Hongyu
Xiong, Ting
Liu, Jie
Huang, Chengxi
Xu, Huipeng
Sun, Huimin
Chen, Weidong
Gref, Ruxandra
Zhang, Jiwen
author_facet He, Siyu
Wu, Li
Li, Xue
Sun, Hongyu
Xiong, Ting
Liu, Jie
Huang, Chengxi
Xu, Huipeng
Sun, Huimin
Chen, Weidong
Gref, Ruxandra
Zhang, Jiwen
author_sort He, Siyu
collection PubMed
description Metal-organic frameworks (MOFs), comprised of organic ligands and metal ions/metal clusters via coordinative bonds are highly porous, crystalline materials. Their tunable porosity, chemical composition, size and shape, and easy surface functionalization make this large family more and more popular for drug delivery. There is a growing interest over the last decades in the design of engineered MOFs with controlled sizes for a variety of biomedical applications. This article presents an overall review and perspectives of MOFs-based drug delivery systems (DDSs), starting with the MOFs classification adapted for DDSs based on the types of constituting metals and ligands. Then, the synthesis and characterization of MOFs for DDSs are developed, followed by the drug loading strategies, applications, biopharmaceutics and quality control. Importantly, a variety of representative applications of MOFs are detailed from a point of view of applications in pharmaceutics, diseases therapy and advanced DDSs. In particular, the biopharmaceutics and quality control of MOFs-based DDSs are summarized with critical issues to be addressed. Finally, challenges in MOFs development for DDSs are discussed, such as biostability, biosafety, biopharmaceutics and nomenclature.
format Online
Article
Text
id pubmed-8424373
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84243732021-09-13 Metal-organic frameworks for advanced drug delivery He, Siyu Wu, Li Li, Xue Sun, Hongyu Xiong, Ting Liu, Jie Huang, Chengxi Xu, Huipeng Sun, Huimin Chen, Weidong Gref, Ruxandra Zhang, Jiwen Acta Pharm Sin B Review Metal-organic frameworks (MOFs), comprised of organic ligands and metal ions/metal clusters via coordinative bonds are highly porous, crystalline materials. Their tunable porosity, chemical composition, size and shape, and easy surface functionalization make this large family more and more popular for drug delivery. There is a growing interest over the last decades in the design of engineered MOFs with controlled sizes for a variety of biomedical applications. This article presents an overall review and perspectives of MOFs-based drug delivery systems (DDSs), starting with the MOFs classification adapted for DDSs based on the types of constituting metals and ligands. Then, the synthesis and characterization of MOFs for DDSs are developed, followed by the drug loading strategies, applications, biopharmaceutics and quality control. Importantly, a variety of representative applications of MOFs are detailed from a point of view of applications in pharmaceutics, diseases therapy and advanced DDSs. In particular, the biopharmaceutics and quality control of MOFs-based DDSs are summarized with critical issues to be addressed. Finally, challenges in MOFs development for DDSs are discussed, such as biostability, biosafety, biopharmaceutics and nomenclature. Elsevier 2021-08 2021-03-13 /pmc/articles/PMC8424373/ /pubmed/34522591 http://dx.doi.org/10.1016/j.apsb.2021.03.019 Text en © 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
He, Siyu
Wu, Li
Li, Xue
Sun, Hongyu
Xiong, Ting
Liu, Jie
Huang, Chengxi
Xu, Huipeng
Sun, Huimin
Chen, Weidong
Gref, Ruxandra
Zhang, Jiwen
Metal-organic frameworks for advanced drug delivery
title Metal-organic frameworks for advanced drug delivery
title_full Metal-organic frameworks for advanced drug delivery
title_fullStr Metal-organic frameworks for advanced drug delivery
title_full_unstemmed Metal-organic frameworks for advanced drug delivery
title_short Metal-organic frameworks for advanced drug delivery
title_sort metal-organic frameworks for advanced drug delivery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424373/
https://www.ncbi.nlm.nih.gov/pubmed/34522591
http://dx.doi.org/10.1016/j.apsb.2021.03.019
work_keys_str_mv AT hesiyu metalorganicframeworksforadvanceddrugdelivery
AT wuli metalorganicframeworksforadvanceddrugdelivery
AT lixue metalorganicframeworksforadvanceddrugdelivery
AT sunhongyu metalorganicframeworksforadvanceddrugdelivery
AT xiongting metalorganicframeworksforadvanceddrugdelivery
AT liujie metalorganicframeworksforadvanceddrugdelivery
AT huangchengxi metalorganicframeworksforadvanceddrugdelivery
AT xuhuipeng metalorganicframeworksforadvanceddrugdelivery
AT sunhuimin metalorganicframeworksforadvanceddrugdelivery
AT chenweidong metalorganicframeworksforadvanceddrugdelivery
AT grefruxandra metalorganicframeworksforadvanceddrugdelivery
AT zhangjiwen metalorganicframeworksforadvanceddrugdelivery